Inference about causation between body mass index and DNA methylation in blood from a twin family study.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
02 2019
Historique:
received: 14 11 2017
accepted: 04 04 2018
revised: 19 03 2018
pubmed: 20 5 2018
medline: 4 1 2020
entrez: 20 5 2018
Statut: ppublish

Résumé

Several studies have reported DNA methylation in blood to be associated with body mass index (BMI), but few have investigated causal aspects of the association. We used a twin family design to assess this association at two life points and applied a novel analytical approach to appraise the evidence for causality. The methylation profile of DNA from peripheral blood was measured for 479 Australian women from 130 twin families. Linear regression was used to estimate the associations of DNA methylation at ~410,000 cytosine-guanine dinucleotides (CpGs), and of the average DNA methylation at ~20,000 genes, with current BMI, BMI at age 18-21 years, and the change between the two (BMI change). A novel regression-based methodology for twins, Inference about Causation through Examination of Familial Confounding (ICE FALCON), was used to assess causation. At a 5% false discovery rate, nine, six and 12 CpGs at 24 loci were associated with current BMI, BMI at age 18-21 years and BMI change, respectively. The average DNA methylation of the BHLHE40 and SOCS3 loci was associated with current BMI, and of the PHGDH locus with BMI change. From the ICE FALCON analyses with BMI as the predictor and DNA methylation as the outcome, a woman's DNA methylation level was associated with her co-twin's BMI, and the association disappeared after conditioning on her own BMI, consistent with BMI causing DNA methylation. To the contrary, using DNA methylation as the predictor and BMI as the outcome, a woman's BMI was not associated with her co-twin's DNA methylation level, consistent with DNA methylation not causing BMI. For middle-aged women, peripheral blood DNA methylation at several genomic locations is associated with current BMI, BMI at age 18-21 years and BMI change. Our study suggests that BMI has a causal effect on peripheral blood DNA methylation.

Sections du résumé

BACKGROUND
Several studies have reported DNA methylation in blood to be associated with body mass index (BMI), but few have investigated causal aspects of the association. We used a twin family design to assess this association at two life points and applied a novel analytical approach to appraise the evidence for causality.
METHODS
The methylation profile of DNA from peripheral blood was measured for 479 Australian women from 130 twin families. Linear regression was used to estimate the associations of DNA methylation at ~410,000 cytosine-guanine dinucleotides (CpGs), and of the average DNA methylation at ~20,000 genes, with current BMI, BMI at age 18-21 years, and the change between the two (BMI change). A novel regression-based methodology for twins, Inference about Causation through Examination of Familial Confounding (ICE FALCON), was used to assess causation.
RESULTS
At a 5% false discovery rate, nine, six and 12 CpGs at 24 loci were associated with current BMI, BMI at age 18-21 years and BMI change, respectively. The average DNA methylation of the BHLHE40 and SOCS3 loci was associated with current BMI, and of the PHGDH locus with BMI change. From the ICE FALCON analyses with BMI as the predictor and DNA methylation as the outcome, a woman's DNA methylation level was associated with her co-twin's BMI, and the association disappeared after conditioning on her own BMI, consistent with BMI causing DNA methylation. To the contrary, using DNA methylation as the predictor and BMI as the outcome, a woman's BMI was not associated with her co-twin's DNA methylation level, consistent with DNA methylation not causing BMI.
CONCLUSION
For middle-aged women, peripheral blood DNA methylation at several genomic locations is associated with current BMI, BMI at age 18-21 years and BMI change. Our study suggests that BMI has a causal effect on peripheral blood DNA methylation.

Identifiants

pubmed: 29777239
doi: 10.1038/s41366-018-0103-4
pii: 10.1038/s41366-018-0103-4
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-252

Références

Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature. 2010;465:721–7.
pubmed: 20535201 doi: 10.1038/nature09230
Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148–59.
pubmed: 18337604 doi: 10.1056/NEJMra072067
Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med. 2010;8:87.
pubmed: 21176133 pmcid: 3016263 doi: 10.1186/1741-7015-8-87
Kuehnen P, Mischke M, Wiegand S, Sers C, Horsthemke B, Lau S, et al. An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 2012;8:e1002543.
pubmed: 22438814 pmcid: 3305357 doi: 10.1371/journal.pgen.1002543
Ding X, Zheng D, Fan C, Liu Z, Dong H, Lu Y, et al. Genome-wide screen of DNA methylation identifies novel markers in childhood obesity. Gene. 2015;566:74–83.
pubmed: 25871514 doi: 10.1016/j.gene.2015.04.032
Almen MS, Nilsson EK, Jacobsson JA, Kalnina I, Klovins J, Fredriksson R, et al. Genome-wide analysis reveals DNA methylation markers that vary with both age and obesity. Gene. 2014;548:61–67.
pubmed: 25010727 doi: 10.1016/j.gene.2014.07.009
Su S, Zhu H, Xu X, Wang X, Dong Y, Kapuku G, et al. DNA methylation of the LY86 gene is associated with obesity, insulin resistance, and inflammation. Twin Res Hum Genet. 2014;17:183–91.
pubmed: 24735745 pmcid: 4090018 doi: 10.1017/thg.2014.22
Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aissi D, Wahl S, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383:1990–8.
pubmed: 24630777 doi: 10.1016/S0140-6736(13)62674-4
Aslibekyan S, Demerath EW, Mendelson M, Zhi D, Guan W, Liang L, et al. Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference. Obesity. 2015;23:1493–501.
pubmed: 26110892 doi: 10.1002/oby.21111
Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou YH, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015;24:4464–79.
pubmed: 25935004 pmcid: 4492394 doi: 10.1093/hmg/ddv161
Al Muftah WA, Al-Shafai M, Zaghlool SB, Visconti A, Tsai PC, Kumar P, et al. Epigenetic associations of type 2 diabetes and BMI in an Arab population. Clin Epigenetics. 2016;8:13.
pubmed: 26823690 pmcid: 4730771 doi: 10.1186/s13148-016-0177-6
Ali O, Cerjak D, Kent JW Jr., James R, Blangero J, Carless MA, et al. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity. Epigenetics. 2016;11:699–707.
pubmed: 27564309 pmcid: 5048720 doi: 10.1080/15592294.2016.1216284
Mendelson MM, Marioni RE, Joehanes R, Liu C, Hedman AK, Aslibekyan S, et al. Association of body mass index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease: a mendelian randomization approach. PLoS Med. 2017;14:e1002215.
pubmed: 28095459 pmcid: 5240936 doi: 10.1371/journal.pmed.1002215
Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81–86.
pubmed: 28002404 doi: 10.1038/nature20784
Wilson LE, Harlid S, Xu Z, Sandler DP, Taylor JA. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort. Int J Obes. 2017;41:194–9.
doi: 10.1038/ijo.2016.184
Geurts YM, Dugue PA, Joo JE, Makalic E, Jung CH, Guan W et al. Novel associations between blood DNA methylation and body mass index in middle-aged and older adults. Int J Obes. 2017; e-pub ahead of print16 Oct 2017; https://doi.org/10.1038/ijo.2017.269 .
Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3:526–34.
pubmed: 26095709 pmcid: 4724884 doi: 10.1016/S2213-8587(15)00127-8
Li S, Wong EM, Southey MC, Hopper JL. Association between DNA methylation at SOCS3 gene and body mass index might be due to familial confounding. Int J Obes. 2017;41:995–6.
doi: 10.1038/ijo.2017.56
Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41:161–76.
pubmed: 22422451 pmcid: 3304531 doi: 10.1093/ije/dyr233
VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M, Kraft P. Methodological challenges in mendelian randomization. Epidemiology. 2014;25:427–35.
pubmed: 24681576 pmcid: 3981897 doi: 10.1097/EDE.0000000000000081
Odefrey F, Stone J, Gurrin LC, Byrnes GB, Apicella C, Dite GS, et al. Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res. 2010;70:1449–58.
pubmed: 20145138 doi: 10.1158/0008-5472.CAN-09-3495
Li S, Wong EM, Joo JE, Jung CH, Chung J, Apicella C, et al. Genetic and environmental causes of variation in the difference between biological age based on DNA methylation and chronological age for middle-aged women. Twin Res Hum Genet. 2015;18:720–6.
pubmed: 26527295 doi: 10.1017/thg.2015.75
Joo JE, Wong EM, Baglietto L, Jung CH, Tsimiklis H, Park DJ, et al. The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array. BMC Biotechnol. 2013;13:23.
pubmed: 23497093 pmcid: 3610215 doi: 10.1186/1472-6750-13-23
Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–9.
pubmed: 24478339 pmcid: 4016708 doi: 10.1093/bioinformatics/btu049
Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012;13:R44.
pubmed: 22703947 pmcid: 3446316 doi: 10.1186/gb-2012-13-6-r44
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27.
pubmed: 16632515 pmcid: 16632515 doi: 10.1093/biostatistics/kxj037
Price ME, Cotton AM, Lam LL, Farre P, Emberly E, Brown CJ, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin. 2013;6:4.
pubmed: 23452981 pmcid: 3740789 doi: 10.1186/1756-8935-6-4
Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
pubmed: 22568884 pmcid: 3532182 doi: 10.1186/1471-2105-13-86
Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc B Methodol. 1995;57:289–300.
Hopper JL, Bui QM, Erbas B, Matheson MC, Gurrin LC, Burgess JA, et al. Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol. 2012;130:1117-22.e11.
doi: 10.1016/j.jaci.2012.08.003
Stone J, Dite GS, Giles GG, Cawson J, English DR, Hopper JL. Inference about causation from examination of familial confounding: application to longitudinal twin data on mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomark Prev. 2012;21:1149–55.
doi: 10.1158/1055-9965.EPI-12-0051
Bui M, Bjornerem A, Ghasem-Zadeh A, Dite GS, Hopper JL, Seeman E. Architecture of cortical bone determines in part its remodelling and structural decay. Bone. 2013;55:353–8.
pubmed: 23643862 doi: 10.1016/j.bone.2013.04.020
Dite GS, Gurrin LC, Byrnes GB, Stone J, Gunasekara A, McCredie MR, et al. Predictors of mammographic density: insights gained from a novel regression analysis of a twin study. Cancer Epidemiol Biomark Prev. 2008;17:3474–81.
doi: 10.1158/1055-9965.EPI-07-2636
Davey CG, Lopez-Sola C, Bui M, Hopper JL, Pantelis C, Fontenelle LF, et al. The effects of stress-tension on depression and anxiety symptoms: evidence from a novel twin modelling analysis. Psychol Med. 2016;46:3213–8.
pubmed: 27604648 doi: 10.1017/S0033291716001884
Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:461S–465S.
pubmed: 16470013 doi: 10.1093/ajcn/83.2.461S
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.
pubmed: 21219177 doi: 10.1146/annurev-immunol-031210-101322
Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010;2010:289645.
doi: 10.1155/2010/289645
Sintes J, Cuenca M, Romero X, Bastos R, Terhorst C, Angulo A, et al. Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+T and invariant NKT cells. J Immunol. 2013;190:21–26.
pubmed: 23225888 doi: 10.4049/jimmunol.1202435
Chatterjee M, Rauen T, Kis-Toth K, Kyttaris VC, Hedrich CM, Terhorst C, et al. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J Immunol. 2012;188:1206–12.
pubmed: 22184727 doi: 10.4049/jimmunol.1102773
Ikeda A, Hasegawa K, Masaki M, Moriguchi T, Nishida E, Kozutsumi Y, et al. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway. J Biochem. 2001;130:773–81.
pubmed: 11726277 doi: 10.1093/oxfordjournals.jbchem.a003048
Masaki M, Ikeda A, Shiraki E, Oka S, Kawasaki T. Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically. Eur J Biochem. 2003;270:76–83.
pubmed: 12492477 doi: 10.1046/j.1432-1033.2003.03363.x
Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol. 2007;8:198–205.
pubmed: 17187069 doi: 10.1038/ni1426
Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA. 2005;102:16309–14.
pubmed: 16260731 doi: 10.1073/pnas.0508237102
Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc Res. 2006;71:103–7.
pubmed: 16414084 doi: 10.1016/j.mvr.2005.11.010
van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27:660–9.
pubmed: 17919942 doi: 10.1016/j.immuni.2007.08.013
McDonald C, Chen FF, Ollendorff V, Ogura Y, Marchetto S, Lecine P, et al. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J Biol Chem. 2005;280:40301–9.
pubmed: 16203728 pmcid: 16203728 doi: 10.1074/jbc.M508538200
Zhao Y, Alonso C, Ballester I, Song JH, Chang SY, Guleng B, et al. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm Bowel Dis. 2012;18:603–12.
pubmed: 21887730 doi: 10.1002/ibd.21851
Richmond RC, Sharp GC, Ward ME, Fraser A, Lyttleton O, McArdle WL, et al. DNA methylation and BMI: investigating identified methylation sites at HIF3A in a causal framework. Diabetes. 2016;65:1231–44.
pubmed: 26861784 pmcid: 4839211 doi: 10.2337/db15-0996
Xu X, Su S, Barnes V, Snieder H, Wang X. Abstract MP55: DNA methylation mediates the effects of obesity on insulin resistance in african american youth and young adults. Circulation 2014; 129(Suppl 1): AMP55.
Richmond RC, Hemani G, Tilling K, Davey Smith G, Relton CL. Challenges and novel approaches for investigating molecular mediation. Hum Mol Genet. 2016;25:R149–R156.
pubmed: 27439390 pmcid: 5036871 doi: 10.1093/hmg/ddw197

Auteurs

Shuai Li (S)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Ee Ming Wong (EM)

Genetic Epidemiology Laboratory, Department of Clinical Pathology, University of Melbourne, Parkville, VIC, Australia.
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.

Minh Bui (M)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Tuong L Nguyen (TL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Ji-Hoon Eric Joo (JE)

Genetic Epidemiology Laboratory, Department of Clinical Pathology, University of Melbourne, Parkville, VIC, Australia.
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.

Jennifer Stone (J)

Centre for Genetic Origins of Health and Disease, Curtin University and the University of Western Australia, Perth, WA, Australia.

Gillian S Dite (GS)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Pierre-Antoine Dugué (PA)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.

Roger L Milne (RL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.

Graham G Giles (GG)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.

Richard Saffery (R)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

Melissa C Southey (MC)

Genetic Epidemiology Laboratory, Department of Clinical Pathology, University of Melbourne, Parkville, VIC, Australia.
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia. j.hopper@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH